Form 4 for FTV Fortive
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-18 · accession 0001266275-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-18 | FTV | MITCHELL KATE | Dir | M - OptEx | $29.58 | +7,131 | 38.9K | +22% | +$210.9K |
| D | 2026-02-19 | 2026-02-18 | FTV | MITCHELL KATE | Dir | S - Sale+OE | $58.34 | -7,131 | 31.8K | -18% | -$416.0K |
| D | 2026-02-19 | 2026-02-18 | FTV | MITCHELL KATE | Dir | M - OptEx | $0.00 | -7,131 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | M | A | 7,131 | $29.58 | 38,906 | D | — | — | (F1) In connection with the spin-off of Ralliant Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment. |
| 2 | Common | Common Stock | 2026-02-18 | S | D | 7,131 | $58.34 | 31,775 | D | — | — | (F2) The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.330 to $58.351. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. (F1) In connection with the spin-off of Ralliant Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment. |
| 3 | Derivative | Director Stock Option (Right to Buy) | 2026-02-18 | M | D | 7,131 | $0.00 | 0 | D | $29.58 · 2016-07-05 to 2026-07-05 | 7,131 Common Stock | (F3) The Director Stock Options reported herein, including the number of options and the exercise price, reflect the Anti-Dilution Adjustment. |